Identification of wheelchair seating criteria in adults with neuromuscular diseases: A Delphi study
- PMID: 37682819
- PMCID: PMC10490879
- DOI: 10.1371/journal.pone.0290627
Identification of wheelchair seating criteria in adults with neuromuscular diseases: A Delphi study
Abstract
Background: Adults with neuromuscular diseases like spinal muscular atrophy or Duchenne muscular dystrophy require full-time use of a wheelchair (WC) and perform all activities of daily living in a sitting position. Optimal configuration of the WC and seating system is essential to maintain the health and quality of life of users. However, few recommendations for configuration exist. The aim of this study was to identify and select 10 WC seating criteria that ensure an optimal sitting posture for health and quality of life.
Methods: A four round Delphi method was used to collect the opinions of WC users and health professionals (HP), separately. First, the HP were asked if they believed that different criteria would apply to each disease. Then the HP and SMA II and DMD WC user experts responded to electronic surveys in 4 rounds.
Results: Overall, 74 experts took part: 31 HP, 21 WC users with SMA II and 22 WC users with DMD. In total, 52% of HP believed that different criteria would apply to each disease. Ten criteria were identified by the HP for SMA II and 10 for DMD. Of the 40 criteria selected, 30 (75%) were common to each panel. Six topics were similar across panels: comfort, access to the joystick, prevention of pain, stability, pressure management and power seat functions. However, power seat functions did not reach consensus between HP and WC users (30-33% of agreement for HP and 93-100% for the WC user panels, p < 0.001).
Conclusion: Adults with SMA II and DMD had similar WC seating needs. Therefore, the same recommendations can be applied to these groups. Further research is necessary to understand the impact of cost on the prescription of power seat functions by health professionals.
Copyright: © 2023 Dupitier et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Orphanet, ‘Prévalence des maladies rares: Données bibliographiques, Classement par prévalence ou incidence décroissante ou par nombre publié de cas’, Les Cah. d’Orphanet, 2019.
-
- Birnkrant D. J. et al., ‘Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.’, Lancet. Neurol., vol. 17, no. 3, pp. 251–267, Mar. 2018, doi: 10.1016/S1474-4422(18)30024-3 - DOI - PMC - PubMed
-
- Kinali F., M; Messina S; Mercuri E; Lehovsky J; Edge G; Manzur AY; Muntoni, ‘2009 Devl Med Chil Neuro Management of scoliosis in Duchenne muscular dystrophy a large 10-year retrospective study.pdf’. Developmental Medicine & Child Neurology, 2006. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
Research Materials